XML 18 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net income $ 11,495 $ 14,165
Adjustments to reconcile net income to net cash used for operating activities:    
Amortization of the value of business acquired   22,823
Amortization and depreciation 4,757 3,761
Amortization of debt issuance costs 92 16
Restricted stock and stock option expense 2,499 9,671
Deferred federal income taxes (10,847) (8,984)
Amortization of bond premium and discount, net 7,398 10,557
Net realized investment losses 9,057 7,216
Gain on disposition of subsidiary (6,872)  
Equity in the earnings of equity method limited liability investments (3,749) (1,448)
Changes in:    
Premiums receivable, net 2,776 18,971
Reinsurance receivables, net 7,142 5,373
Funds held by ceding insurers (3,319) 661
Unpaid losses and loss adjustment expenses (15,665) (35,452)
Unearned premiums (7,724) 4,608
Ceded balances payable 7,129 (11,909)
Other assets and liabilities, net (19,348) (13,199)
Contingent commissions (1,677) (2,909)
Federal income tax receivable/payable 172 (2,048)
Deferred acquisition costs, net 1,376 (32,160)
Prepaid reinsurance premiums 5,962 9,081
Net cash used for operating activities (9,346) (1,206)
Cash flows from investing activities:    
Cash release from escrow for business acquisition   113,696
Acquisition of business, net of cash acquired   (92,336)
Proceeds from sale of fixed maturities 279,659 290,580
Proceeds from sale of equity securities 34,976 34,161
Proceeds from sale of preferred stock   1,540
Proceeds from maturity of fixed maturities 61,437 146,870
Proceeds from limited partnership distribution 6,350 4,287
Proceeds from disposition of subsidiary, net of cash and cash equivalents disposed of $1,269 16,937  
Amounts paid in connection with derivatives (11,527) (7,072)
Purchases of fixed maturities (344,514) (485,153)
Purchases of equity securities (34,945) (32,434)
Purchases of other invested assets (2,643) (2,250)
Net cash provided by (used for) investing activities 5,730 (28,111)
Cash flows from financing activities:    
Net borrowings under margin borrowing facilities 1,050 21,114
Proceeds from issuance of subordinated notes   100,000
Debt issuance cost (14) (3,659)
Tax benefit on share-based compensation expense 127 58
Purchase of A ordinary shares (805) (333)
Net cash provided by financing activities 358 117,180
Net change in cash and cash equivalents (3,258) 87,863
Cash and cash equivalents at beginning of period 67,037 58,823
Cash and cash equivalents at end of period $ 63,779 $ 146,686